EUVIMEDEUVIMED entdecken
Open Access

Low-dose-rate brachytherapy and long-term treatment outcomes in patients younger than 60 years of age

Alexander Armstrong, Huong Ho, MBiostat Mark Tacey, Damien Bolton, Yee Chan, Alwin Tan, Chee Wee Cham, Trung Pham, Kevin McMillan, George Koufogiannis, Grad Dip, Paul Manohar und 6 weitere

Journal of Contemporary Brachytherapy · 2024 · 16 (1) · 6-11

DOI: 10.5114/jcb.2024.135630 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Contemporary Brachytherapy, 2024. Verfasst von Alexander Armstrong und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, North Coast Cancer Institute, Lismore Cancer Care and Hematology Unit, Lismore, NSW, Australia. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Low-dose-rate (LDR) brachytherapy in young men remains controversial amongst urologists due to their concerns regarding long-term biochemical control and treatment-related toxicities. The purpose of this study was to evaluate the treatment outcomes of men under 60 years of age who underwent LDR brachytherapy with iodine-125 (125I) for clinically localized low- to intermediate-risk prostate cancer. Material and methods: All consecutive patients with clinically localized prostate cancer treated at our institution from 2003 to 2016 with 125I monotherapy were included in the study. Prescription dose was 145.0 Gy modified peripheral loading (MPD). All patients were assessed for biochemical progression-free survival using Phoenix definition (nadir +2 ng/ml), clinical progression-free survival, overall survival (OS), and any associated treatment toxicity.

Results

A total of 161 patients were included, with a median follow-up of 6.8 years (range, 3-14.54 years). Median age at implant was 57 years (range, 53-59 years). Mean prostate specific antigen (PSA) level at diagnosis was 4.43 ng/ml (SD = 2.29). Majority of men had low-risk prostate cancer (70.2%). Biochemical progression-free survival at 8 years was 94% for the entire cohort. Median PSA at 4 years was 0.169 (IQR, 0.096-0.360), with 45% of patients having a PSA greater than 0.2. OS was 96.9%, with 5 deaths reported but only one was secondary to prostate cancer. Late grade > 2 genitourinary toxicities were reported in 18 patients (11.2%). Three patients (1.9%) developed secondary cancers, all considered unrelated to their LDR brachytherapy.

Conclusions

With excellent long-term treatment outcomes and minimal associated toxicities, our results showed that LDR brachytherapy can be an effective treatment of choice in younger men.

Schlagwörter

Stichwörter der Autor:innen

brachytherapylong-term treatment outcomeslow-dose-rateprostate cancertoxicity

Autor:innen und Institutionen

  • Department of Radiation Oncology, North Coast Cancer Institute, Lismore Cancer Care and Hematology Unit, Lismore, NSW, Australia.
  • GenesisCare Ringwood Vic., Australia.
  • Department of Radiation Oncology, Austin Health, Heidelberg, Australia.
  • Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
  • Department of Surgery, Austin Health, Heidelberg, Vic., Australia.
  • Department of Surgery, Olivia Newton-John Cancer Wellness and Research Centre, Austin Health, Heidelberg, Vic., Australia.

Zitieren

APA

Armstrong, A., Ho, H., Mark Tacey, M., Bolton, D., Chan, Y., Tan, A., Cham, C. W., Pham, T., McMillan, K., Koufogiannis, G., Dip, G., Manohar, P., Guerrieri, M., Ng, M., Joon, D. L., Foroudi, F., Tan, M. Y., & Chao, M. (2024). Low-dose-rate brachytherapy and long-term treatment outcomes in patients younger than 60 years of age. Journal of Contemporary Brachytherapy, 16(1), 6-11. https://doi.org/10.5114/jcb.2024.135630

Vancouver

Armstrong A, Ho H, Mark Tacey M, Bolton D, Chan Y, Tan A, et al. Low-dose-rate brachytherapy and long-term treatment outcomes in patients younger than 60 years of age. Journal of Contemporary Brachytherapy. 2024;16(1):6-11. doi:10.5114/jcb.2024.135630

BibTeX
@article{Armstrong2024,
  author = {Armstrong, Alexander and Ho, Huong and Mark Tacey, MBiostat and Bolton, Damien and Chan, Yee and Tan, Alwin and Cham, Chee Wee and Pham, Trung and McMillan, Kevin and Koufogiannis, George and Dip, Grad and Manohar, Paul and Guerrieri, Mario and Ng, Michael and Joon, Daryl Lim and Foroudi, Farshad and Tan, Mun Yee and Chao, Michael},
  title = {Low-dose-rate brachytherapy and long-term treatment outcomes in patients younger than 60 years of age},
  journal = {Journal of Contemporary Brachytherapy},
  year = {2024},
  volume = {16},
  number = {1},
  pages = {6--11},
  doi = {10.5114/jcb.2024.135630}
}
Kostenlos starten →